Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
05/2008
05/28/2008CN100390264C A device.
05/27/2008US7378573 Transgenic plants and plant cells; isolated polynucleotides encoding proteins comprising amino acid sequence 2; vectors, host cells
05/27/2008US7378550 Process for preparing reverse transcriptase inhibitors
05/27/2008US7378506 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
05/27/2008US7378492 CD40-related receptor that binds CD40L
05/22/2008US20080118948 Generating vector comprising regulatory sequences associated with protein translation elongation factor TU (P EF-TU); improving exogenous gene expression
05/21/2008EP1699934A4 Soluble analyte detection and amplification
05/21/2008EP1687406A4 Nucleic acid detection method having increased sensitivity
05/20/2008US7375117 Polypeptides
05/20/2008US7375077 In vivo synthesis of connective tissues
05/14/2008EP1727890B1 Mutated xylose reductase in xylose-fermentation by s. cerevisiae
05/14/2008EP1660184A4 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
05/14/2008EP1649007A4 Methods for ex-vivo expanding stem/progenitor cells
05/14/2008EP1599727B1 Method for producing an immobilised virus carrier and the use thereof
05/14/2008EP1409712A4 Microfermentor device and cell based screening method
05/14/2008CN101177456A Modified transferrin fusion proteins
05/14/2008CN101177455A Modified transferrin fusion proteins
05/13/2008US7371851 Hybridizing and ligating double stranded nucleic acids; identifying binary codes using labeled probes; does not require use of restriction enzymes
05/13/2008US7371822 Polypeptide of given sequence; use in prevention and treatment of cardiovascular, metabolic, inflammatory disorders;
05/13/2008US7371558 Genetically modified eschrichia strain which is capable of biocoversion a single cacrbon source into 1, 3 propanediol using fermentation; bioreactors
05/13/2008US7371517 High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa
05/08/2008US20080108582 Methods And Compositions For Combinatorial Approaches To Cancer Gene Therapy
05/07/2008EP1918368A2 Enzyme stabilization by cationic surfactants
05/07/2008EP1670902A4 METHOD AND COMPOSITION FOR ENHANCING i IN VITRO /i EMBRYO DEVELOPMENT BY SUPPLEMENTING CULTURE MEDIUM WITH PROSTAGLANDIN OR A PROSTAGLANDIN ANALOG
05/07/2008CN101173262A Method to improve the stability and broaden the PH range of family G/11 xylanases
05/06/2008US7368284 Porcine CMP-N-Acetylneuraminic acid hydroxylase gene
05/06/2008US7368237 Kit for screening for an apoptosis modulator; an isolated cell death-related nuclease (CRN)polypeptide or fragment, polynucleotide encoding fragment, and/or orthologs; medical diagnosis; genetic engineering and expression; hybridization
05/01/2008US20080102036 Biocompatible Fluorescent Silicon Nanoparticles
04/2008
04/30/2008EP1649000A4 Seeding pancreatic cells on porous matrices
04/30/2008EP1556511A4 Reverse transcription on microarrays
04/30/2008CN100384880C Modified peptides as therapeutic agents
04/30/2008CN100384879C Modified peptides as therapeutic agents
04/30/2008CN100384862C Method of alpha-selective glycosylation
04/29/2008US7365184 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production
04/24/2008US20080096840 Gene expression inhibition by contacting cells which express kinase suppressor of Ras (KSR) with a nucleic acid which is complementary to a portion of the mRNA encoding KSR; antitumor, anticarcinogenic, antimetastasis and antiproliferative agents
04/24/2008US20080093579 Organic Cooling Medium And Its Uses
04/23/2008EP1914314A2 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
04/23/2008EP1639137A4 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
04/23/2008CN101166752A Compositions and methods for inhibiting white spot syndrome virus (WSSV) infection
04/23/2008CN101164623A Compositions comprising viruses and methods for concentrating virus preparations
04/22/2008US7361503 Sequences encoding hepatitis C virus glycoproteins
04/22/2008US7361488 Monitoring adjustment in transcription products during gene amplification
04/17/2008US20080090770 Modulation of Muc1 Mediated Signal Transduction
04/16/2008EP1639090A4 Compositions and methods for treating and diagnosing cancer
04/15/2008US7358054 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design
04/15/2008US7357916 Method for creating a uniform vascular wound in zebrafish or zebrafish larva
04/10/2008WO2006138466B1 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
04/09/2008EP1908842A2 PEF-TU expression units
04/09/2008EP1680437A4 Motoneuronotrophic factor gene sequences
04/09/2008EP1633852A4 Sppls as modifiers of the p53 pathway and methods of use
04/08/2008US7354932 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
04/02/2008EP1905829A2 Templated molecules and methods for using such molecules
04/02/2008EP1904851A2 Method for evaluating cell populations
04/02/2008EP1708560A4 Corn plant mon88017 and compositions and methods for detection thereof
04/02/2008EP1682664A4 Methods for the production of apolipoproteins in transgenic plants
04/02/2008EP1658364A4 Tubulin regulatory elements for use in plants
04/02/2008EP1565741A4 Inferring gene regulatory networks from time-ordered gene expression data using differential equations
04/02/2008CN100378217C Method to improve stability and broaden PH range of family G/11 xylanases
04/01/2008US7351537 Variants of cyan fluorescent protein with improved fluorescent properties
03/2008
03/27/2008WO2005037998A3 Methods and compositions related to a matrix chip
03/27/2008US20080076130 Molecular haplotyping of genomic dna
03/27/2008US20080076116 Kits for Detection of Segmented Negative Strand RNA Viruses
03/26/2008EP1601795A4 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent
03/25/2008US7348420 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
03/20/2008US20080070791 Libraries Of Chimeric Cellulose Binding Proteins And Methods Of Use Thereof
03/20/2008US20080069773 Novel Sodium Channel
03/19/2008EP1898692A2 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
03/19/2008EP1616017A4 A method for producing para-hydroxystyrene and other multifunctional aromatic compounds using two-phase extractive fermentation
03/19/2008EP0594669B9 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
03/18/2008US7344844 Can be used for the treatment of diabetes or for delaying the onset of diabetes
03/18/2008CA2191213C Lactobacillus strains of human origin, their compositions and uses thereof
03/13/2008US20080064741 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/13/2008US20080064648 Methods and Compositions Relating to Lipid Accumulation
03/13/2008US20080064647 A polyvalent multimeric complex formed from a plurality of circularly permuted chimeric pRNA molecules, each carrying a stabilized biologically active moiety; degradation resistant stabilized ribozyme is correctly folded such that it remains intracellularly active
03/13/2008US20080064042 Compositions for detection and analysis of polynucleotides using light harvesting multichromophores
03/12/2008EP1897552A1 Polymer-conjugated glycosylated neublastin
03/12/2008EP1897548A1 T cell regulation
03/12/2008EP1896023A2 Chemokine receptor binding compounds
03/12/2008CN100374551C Compositions comprising viruses and methods for concentrating virus preparations
03/11/2008US7341852 Methods of decoupling reaction scale and protein synthesis yield in batch mode
03/11/2008US7341837 Identifying preferential nucleotide sequences in solution using liquid phase mixtures; high throughput assay; bioparticle replication
03/11/2008US7341552 Gene sets for glioma classification
03/06/2008US20080060089 Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom
03/06/2008US20080058275 Rna Interferases And Methods Of Use Thereof
03/06/2008US20080058259 Improve metabolism of humans; administering mixture of insulin-like growth factor and growth hormone; particlar pediatic humans
03/06/2008US20080058222 Obtaining faithful RNA and cDNA expression libraries; extraction from intact tissue cultured in three dimensional sponge gels; tumor development prognosis
03/06/2008US20080057576 Reactor and Method for Solid State Fermentation
03/06/2008US20080057546 Generating preferentisl nuleotide seuence using adapter molecules to mediate binding between first and second molecules; gene libraries; genomic analysis
03/06/2008US20080057071 Use Of Hedgehog Pathway Inhibitors In Small-Cell Lung Cancer
03/05/2008EP1537187A4 Organic species that facilitate charge transfer to or from nanostructures
03/05/2008CN101137749A Novel microbial enzymes and their use
03/05/2008CN100372928C Serum free cultivation of primate embryonic stem cells
03/04/2008US7339044 Nematode PAN and ZP receptor-like sequences
03/04/2008US7339042 cytotoxic fusion proteins that are useful for selectively killing endothelial cells in blood vessels that feed tumors
03/04/2008US7339032 Polypeptides, fragments and homologues; vectors, host cells, antibodies; genetic engineering and expression; treatment of urogenital, sexual, metabolic, inflammatory, pregnancy, and g-protein coupled receptor disorders; drug screening
03/04/2008US7338762 Attached covalently to one or more beads; dispersing the probe beads in a thixotropic agent, scanning for a detectable signal, isolating the target biomolecule; high throughput assays
03/04/2008US7338517 Tissue scaffold having aligned fibrils and artificial tissue comprising the same
02/2008
02/28/2008WO2006138466A3 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
02/28/2008US20080050799 Liquid crystals with reduced toxicity and applications thereof
02/28/2008US20080050785 Method for Producing an L-Amino Acid
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 100